MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

Search

Day One Biopharmaceuticals Inc

Chiusa

SettoreSettore sanitario

7.69 -0.52

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

7.53

Massimo

7.82

Metriche Chiave

By Trading Economics

Entrata

-103M

-66M

Vendite

-65M

29M

EPS

-0.63

Margine di Profitto

-224.986

Dipendenti

181

EBITDA

-94M

-65M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+336.05% upside

Dividendi

By Dow Jones

Utili prossimi

6 mag 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-505M

724M

Apertura precedente

8.21

Chiusura precedente

7.69

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bullish Evidence

Day One Biopharmaceuticals Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

28 apr 2025, 23:27 UTC

Notizie principali

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- 2nd Update

28 apr 2025, 23:07 UTC

Notizie principali

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- Update

28 apr 2025, 23:03 UTC

Utili

Waste Management 1Q Profit Falls, Revenue Misses Estimates

28 apr 2025, 23:47 UTC

Discorsi di Mercato

Gold Edges Lower as Traders Assess Mixed Signals From Treasury Secretary Bessent -- Market Talk

28 apr 2025, 23:17 UTC

Utili

Jiangxi Copper 1Q Rev CNY111.61B Vs. CNY122.52B >0358.HK

28 apr 2025, 23:17 UTC

Utili

Jiangxi Copper 1Q Net CNY1.95B Vs. Net CNY1.71B >0358.HK

28 apr 2025, 23:13 UTC

Utili

China Merchants Securities: Higher Interest Income, Fee Income Also Aided 1Q Results>600999.SH

28 apr 2025, 23:13 UTC

Utili

China Merchants Securities 1Q Rev CNY4.71B Vs. CNY4.30B >600999.SH

28 apr 2025, 23:13 UTC

Utili

China Merchants Securities: Gains From Investments in Financial Instruments Supported Results >600999.SH

28 apr 2025, 23:13 UTC

Utili

China Merchants Securities 1Q Net CNY2.31B Vs. Net CNY2.16B >600999.SH

28 apr 2025, 23:08 UTC

Utili

China Longyuan Power: 1Q Power Generation Declined 4.42% on Year>0916.HK

28 apr 2025, 23:08 UTC

Utili

China Longyuan Power 1H Rev CNY8.14B Vs. CNY8.07B >0916.HK

28 apr 2025, 23:08 UTC

Utili

China Longyuan Power 1H Net CNY1.98B Vs. Net CNY2.53B >0916.HK

28 apr 2025, 23:04 UTC

Utili

Huaneng Power: 1Q Net Was Mainly Driven By Decline in Domestic Fuel Costs >0902.HK

28 apr 2025, 23:04 UTC

Utili

Huaneng Power: Decrease in Electricity Tariffs Weighed on Rev >0902.HK

28 apr 2025, 23:04 UTC

Utili

Huaneng Power 1Q Rev CNY60.33B ; Down 7.7% on Year>0902.HK

28 apr 2025, 23:04 UTC

Utili

Huaneng Power 1Q Net CNY4.97B; up 8.2% on Year >0902.HK

28 apr 2025, 23:00 UTC

Utili

Jiangsu Expressway 1Q Rev CNY4.78B Vs. CNY3.47B >0177.HK

28 apr 2025, 23:00 UTC

Utili

Jiangsu Expressway: 1Q Rev Rose Due to Increase in Road Construction Projects >0177.HK

28 apr 2025, 23:00 UTC

Utili

Jiangsu Expressway: Decline in Investment Income, Fall in Revenue Post Asset Disposal Weighed on 1Q Net >0177.HK

28 apr 2025, 23:00 UTC

Utili

Jiangsu Expressway 1Q Net CNY1.21B Vs. Net CNY1.25B >0177.HK

28 apr 2025, 22:57 UTC

Notizie principali

Trump Signs Order Requiring Nationwide List of Sanctuary Cities and States -- 8th Update

28 apr 2025, 22:55 UTC

Utili

Tsingtao Brewery: Higher Sales Volumes of Beer Supported Results >0168.HK

28 apr 2025, 22:55 UTC

Utili

Tsingtao Brewery 1Q Net CNY1.71B Vs. Net CNY1.60B >0168.HK

28 apr 2025, 22:55 UTC

Utili

Tsingtao Brewery 1Q Rev CNY10.45B Vs. CNY10.15B >0168.HK

28 apr 2025, 22:52 UTC

Utili

S.F. Holding: Results Supported by Higher Contributions From Logistics Business >002352.SZ

28 apr 2025, 22:52 UTC

Utili

S.F. Holding 1Q Net CNY2.23B Vs. Net CNY1.91B >002352.SZ

28 apr 2025, 22:52 UTC

Utili

S.F. Holding: Cost Controls Also aided 1Q Results >002352.SZ

28 apr 2025, 22:52 UTC

Utili

S.F. Holding 1Q Rev CNY69.85B Vs. CNY65.34B >002352.SZ

28 apr 2025, 22:46 UTC

Utili

Shandong Gold Mining: Increase in Selling Price of Gold Supported Results>600547.SH

Confronto tra pari

Modifica del prezzo

Day One Biopharmaceuticals Inc Previsione

Obiettivo di Prezzo

By TipRanks

336.05% in crescita

Previsioni per 12 mesi

Media 33.75 USD  336.05%

Alto 43 USD

Basso 21 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Day One Biopharmaceuticals Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

9 ratings

8

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

7.39 / 7.9Supporto e resistenza

A breve termine

Very Strong Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.